FDA Clears New Menopause Drug

The non-hormonal treatment was found to significantly reduce hot flashes and night sweats associated with menopause.

Ap
AP

According to a recent USA Today article, the FDA has approved Veozah, a drug developed by Astellas Pharma, to treat menopause symptoms. Veozah is a once-a-day pill that has been found to significantly reduce hot flashes and night sweats associated with menopause by blocking a chemical called neurokinin B (NKB) in the brain, which regulates body temperature. This drug is intended to replace traditional hormonal therapies that aren’t suitable for all patients, especially those with certain health conditions.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
Sustainable Healthcare Packaging Solutions That Work
Industry leaders share proven strategies for reducing packaging emissions by up to 70% while meeting safety and regulatory requirements.
Read More
Sustainable Healthcare Packaging Solutions That Work